Cancerappy obtained the positive resolution of the Neotec 2020 program.

CancerAppy was one of the 24 projects selected to exhibit at the B-venture 2020 Bilbao.

Version 6.0 AI 1.0

AI + Drug Interaction / Personalized Medicine

Version 5.0

Code rewritten. Drug Interaction

CancerAppy raised a pre-seed round of € 120K

Version 4.0

Tested at 6 hospitals and universities

Cancerappy is founded in Bilbao as a startup

Since 2017 we have been collecting a large amount of data of approved and investigational drugs.

We have developed up to three versions for internal use, that have served as the basis for the current version.

Non commercial version.